Vaccine News and Research

Latest Vaccine News and Research

Review explores whether HPV vaccination of young men is warranted and cost effective

Vaccination against human papilloma virus (HPV) is recommended for young women to protect them from HPV infection and cervical cancer. Male HPV immunization is increasingly a topic of debate in the medical community. A timely review of the literature published in Viral Immunology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers, explores whether HPV vaccination of young men is warranted and cost effective.

8 Aug 2012

UMass Medical, Serum Institute of India partner on anti-rabies monoclonal antibody pivotal trial

A pivotal clinical trial for an anti-rabies human monoclonal antibody (RMAb) being developed through a collaborative partnership between MassBiologics of the University of Massachusetts Medical School and the Serum Institute of India, Ltd., is starting to enroll patients.

8 Aug 2012

BioDiem granted European patent for antimicrobial drug

Australian vaccine development company BioDiem Ltd (ASX: BDM) announced today the successful granting of a key European patent for its synthetic antimicrobial compound BDM-I. BDM-I is a novel compound active against a range of pathogenic micro-organisms including bacteria, fungi and protozoa. The patent provides protection around BDM-I as a treatment for vulvovaginitis, a general term for inflammation of the vulva or vagina.

7 Aug 2012

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

BioDiem recently signed a collaborative agreement with The Royal Melbourne Institute of Technology (RMIT) for the development of non-influenza vaccines using BioDiem’s proprietary live attenuated influenza virus (LAIV) technology.

7 Aug 2012

Advances in HIV/AIDS therapy and the International AIDS Conference: an interview with Professor Sharon Lewin

The anti-HIV drugs, also known as anti-retroviral therapy, came about in the mid ‘90’s. These involved using at least 3 different drugs together.

7 Aug 2012

Commercial cattle vaccine can effectively reduce levels of E. coli by more than 50%

A commercial vaccine for cattle can effectively reduce levels of E. coli by more than 50 percent, a Kansas State University study has found. The vaccine is also effective using two doses instead of the recommended three doses, which can help cut costs for the beef industry.

7 Aug 2012

New research center to expedite study of gene transfer approach

In an alliance aimed at bringing a new, personalized immunotherapy approach to patients with a wide variety of cancers, the University of Pennsylvania and Novartis announced today an exclusive global research and licensing agreement to further study and commercialize novel cellular immunotherapies using chimeric antigen receptor (CAR) technologies.

6 Aug 2012

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Genocea Biosciences announced today the presentation of new data supporting its novel approach to developing a first-in-class, protein subunit therapeutic vaccine for Herpes Simplex Virus type 2 (HSV-2).

6 Aug 2012

Novartis, Penn partner to study and commercialize novel cellular immunotherapies for cancer

6 Aug 2012

Drug molecules designed for influenza may be adapted to treat other viruses

St. Jude Children's Research Hospital study shows how compounds blocking an enzyme universal to all influenza viruses may allow development of new antiviral drugs that also avoid the problem of drug resistance

3 Aug 2012

Science magazine recaps issues discussed at AIDS 2012

Science looks back at the XIX International AIDS Conference (AIDS 2012), which ended last week in Washington, D.C., writing, "The battle against HIV is having more success than ever. ... But several presentations made clear that a gulf separates aspirations from reality when it comes to 'ending AIDS,' which [Secretary of State Hillary] Clinton and many other prominent speakers at the conference emphasized was now possible."

3 Aug 2012

Partners in health reports on efforts to curb Haiti's cholera epidemic using oral vaccinations

"In April, Partners In Health [PIH] responded to Haiti's cholera epidemic by providing oral vaccinations to 45,000 people living in the country's Artibonite region -- specifically, to two rice-farming communities hit hard by cholera," Louise Ivers, senior health and policy adviser at PIH, reports in an article on the organization's webpage.

3 Aug 2012

Rodent study shows potential for development of more virulent malaria if 'leaky' vaccine used

Using a rodent model to examine the long-term effects of a potential malaria vaccine, a new study published in PLoS Biology by researchers at Penn State University shows that the vaccine could lead to the development of more virulent forms of malaria, the PLoS blog "Biologue" reports.

3 Aug 2012

Australian scientists discover new virus in bats

Australian scientists have discovered a new virus in bats that could help shed light on how Hendra and Nipah viruses cause disease and death in animals and humans. The new virus - named 'Cedar' after the Queensland location where it was discovered - is a close relative of the deadly Hendra and Nipah viruses.

3 Aug 2012

GAVI Alliance announces plans to roll out vaccines in countries isolated by war, secrecy

The New York Times reports on efforts by the GAVI Alliance to deliver vaccines for children in war-torn and secretive countries. According to the newspaper, the non-profit group "sold to North Korea a vaccine against five diseases, and has announced plans to roll out other vaccines soon in Yemen, the Republic of Congo and Pakistan."

2 Aug 2012

Possible molecular link between circadian rhythm disturbances and increased inflammatory response

Scientists have known for some time that throwing off the body's circadian rhythm can negatively affect body chemistry. In fact, workers whose sleep-wake cycles are disrupted by night shifts are more susceptible to chronic inflammatory diseases such as diabetes, obesity and cancer.

2 Aug 2012

People with diabetes, hypertension and hyperlipidemia have difficultly managing all 3 conditions

Most people who have diabetes, high blood pressure, and high cholesterol have difficultly managing all three conditions; indeed, success is fleeting for those who do manage all three, according to a Kaiser Permanente Institute for Health Research study that appears online in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes.

1 Aug 2012

GSK begins shipping the first lots of 2012-2013 seasonal influenza vaccines

GlaxoSmithKline announced today it has begun shipping the first lots of 2012-2013 FluLaval (Influenza virus vaccine) and Fluarix (Influenza Virus Vaccine) to CDC distribution centers and U.S. healthcare providers.

1 Aug 2012

HIV would 'remain a threat' even if world achieved 'AIDS-free generation' by any definition

Lawrence Altman, former senior medical correspondent for the New York Times, writes in an opinion analysis in the newspaper that while there was much discussion about "ending the AIDS epidemic" and an "AIDS-free generation" at the XIX International AIDS Conference (AIDS 2012) last week in Washington, D.C., "[o]ne obstacle is a failure to clearly define the epidemic or what it means to have an AIDS-free generation."

1 Aug 2012

Poor sleep can reduce effectiveness of vaccines

As moms have always known, a good night's sleep is crucial to good health -- and now a new study led by a UCSF researcher shows that poor sleep can reduce the effectiveness of vaccines.

1 Aug 2012

Vaccine News and Research

Latest Vaccine News and Research

Review explores whether HPV vaccination of young men is warranted and cost effective

UMass Medical, Serum Institute of India partner on anti-rabies monoclonal antibody pivotal trial

BioDiem granted European patent for antimicrobial drug

Creating new non-influenza vaccines: an interview with Julie Phillips, CEO of BioDiem

Advances in HIV/AIDS therapy and the International AIDS Conference: an interview with Professor Sharon Lewin

Commercial cattle vaccine can effectively reduce levels of E. coli by more than 50%

New research center to expedite study of gene transfer approach

Genocea announces new data that supports novel approach for development of HSV-2 vaccine

Novartis, Penn partner to study and commercialize novel cellular immunotherapies for cancer

Drug molecules designed for influenza may be adapted to treat other viruses

Science magazine recaps issues discussed at AIDS 2012

Partners in health reports on efforts to curb Haiti's cholera epidemic using oral vaccinations

Rodent study shows potential for development of more virulent malaria if 'leaky' vaccine used

Australian scientists discover new virus in bats

GAVI Alliance announces plans to roll out vaccines in countries isolated by war, secrecy

Possible molecular link between circadian rhythm disturbances and increased inflammatory response

People with diabetes, hypertension and hyperlipidemia have difficultly managing all 3 conditions

GSK begins shipping the first lots of 2012-2013 seasonal influenza vaccines

HIV would 'remain a threat' even if world achieved 'AIDS-free generation' by any definition

Poor sleep can reduce effectiveness of vaccines

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in